glutamine has been researched along with Cancer of Head in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.78) | 18.2507 |
2000's | 4 (11.11) | 29.6817 |
2010's | 20 (55.56) | 24.3611 |
2020's | 11 (30.56) | 2.80 |
Authors | Studies |
---|---|
Barbeau, LMO; Bussink, J; de Jong, MC; Keulers, TG; Koch, A; Melotte, V; Rouschop, KMA; Savelkouls, KGM; van Gisbergen, MW; Wanders, RG; Zonneveld, MI | 1 |
Ding, Z; Ke, Y; Lang, L; Loveless, R; Qiu, P; Saba, NF; Shay, C; Teng, Y; Wang, F; Xie, J; Zhao, X | 1 |
Afarinkia, K; Basheer, HA; Elsalem, L; Hunter, K; Salem, A; Tailor, A | 1 |
Guo, B; Han, Y; He, Y; Liu, L; Liu, S; Xu, S; Zhang, X | 1 |
Higaki, Y; Kunitake, N; Kuroki, K; Masuda, M; Rikimaru, F; Toh, S | 1 |
Inohara, H; Ito, T; Tsujimoto, T; Wasa, M | 1 |
Aoki, D; Banno, K; Kawaguchi, S; Masuko, T; Minami, Y; Nagano, O; Nakayama, H; Okazaki, S; Otsuki, Y; Saya, H; Suina, K; Umene, K; Yamasaki, J; Yoshikawa, M | 1 |
Čipak Gašparović, A; Gall Trošelj, K; Konjevoda, P; Milković, L; Mojzeš, A; Novak Kujundžić, R; Šimunić, D; Tomljanović, M; Žarković, N; Đaković, N | 1 |
Huang, Y; Jin, R; Liu, R; Luo, J; Shuai, Y; Wang, X; Zhang, Z | 1 |
Al-Ameer, HJ; Al-Rawashdeh, B; Almasri, Y; Hijazi, E; Jarrar, Y; Shomaf, M; Sobiahe, A; Zihlif, M | 1 |
Chang, HW; Han, MW; Kim, MR; Kim, SH; Kim, SW; Kim, SY; Lee, JC; Lee, M; Lee, YS; Nam, HY; Park, JJ | 1 |
Bueno, NB; Guedes, GDS; Lyra, MMF; Meira, JEC | 1 |
Abu-Zaid, A; Alqahtani, KH; Alsini, AY; Alsubaie, HM; Alsubaie, KM; Alzahrani, FR; Pathak, AK; Sayed, S | 1 |
Cengiz, M; Karabulut, E; Ozyigit, G; Yazici, G; Yuce Sari, S; Yuce, D | 1 |
Chaves Conde, M; Fuentes Pradera, J; García Luna, PP; Irles Rocamora, JA; Ortiz Gordillo, MJ; Osorio Gómez, GF; Pachón Ibáñez, J; Pereira Cunill, JL; Quintana Ángel, B; Serrano Aguayo, P | 1 |
Atkinson, C; Howes, N; Lewis, SJ; Thomas, S | 1 |
Chen, CH; Chen, F; Chuang, HY; Fang, PT; Huang, CJ; Huang, CM; Huang, MY; Lee, HH; Luo, KH; Wang, YT; Wang, YY; Yuan, SS | 1 |
Guo, Y; Li, X; Lu, C; Luo, L; Paul, B; Saxena, D; Seo, W; Wang, Y; Yan, W; Yang, J; Zhang, R | 1 |
Ariyawardana, A; Barasch, A; Bossi, P; Cheng, KKF; Elad, S; Gobbo, M; Hovan, A; Jensen, SB; Kandwal, A; Lalla, RV; Lucas, AS; Majorana, A; Nasr, NM; Ottaviani, G; Pentenero, M; Ranna, V; Rouleau, T; Saca-Hazboun, H; Treister, NS; Vaddi, A; Yarom, N; Zur, E | 1 |
Ballesteros-Pomar, MD; Calleja-Fernández, A; Cano-Rodríguez, I; Vidal-Casariego, A | 1 |
Ariyawardana, A; Barasch, A; Bowen, J; Elad, S; Hovan, A; Jarvis, V; Jensen, SB; Lalla, RV; Yarom, N; Zadik, Y | 1 |
Hammami, B; Hamza-Chaffai, A; Kallel, I; Khlifi, R; Rebai, A | 1 |
Azman, M; Mohd Yunus, MR; Sulaiman, S; Syed Omar, SN | 1 |
Hayashi, N; Inohara, H; Ito, T; Maeda, K; Nakahara, S; Takagi, T; Takenaka, Y; Tsugane, M; Tsujimoto, T; Uejima, E; Wasa, M; Yamamoto, Y | 1 |
Drakoulis, N; Papanikolopoulou, A; Syrigos, KN | 1 |
Chan, AL; Leung, HW | 1 |
Fan, Z; Li, X; Lu, H; Lu, Y; Qiu, S | 1 |
Jang, HJ; Kim, EH; Park, JY; Roh, JL; Shin, D | 1 |
Rosenthal, DI; Trotti, A | 1 |
Gunduz, M; Mita, Y; Naomoto, Y; Ouchida, M; Sakai, A; Shimizu, K; Tanabe, S; Toyooka, S; Yamamoto, H; Yasuda, Y | 1 |
Davis-Malesevich, M; Fokt, I; Frederick, MJ; Myers, JN; Ow, TJ; Pickering, CR; Priebe, W; Sandulache, VC; Zhou, G | 1 |
Bianchini, C; Ciorba, A; Pastore, A; Pelucchi, S; Stomeo, F | 1 |
Cortes-Funes, H; Gamarra, S; Hitt, R; Manso, L; Medina, PP; Quintela-Fandino, M; Sanchez-Cespedes, M | 1 |
Chen, HC; Fang, FM; Hsiung, CY; Hsu, HC; Huang, EY; Leung, SW; Sun, LM; Wang, CJ; Yeh, SA | 1 |
Mazeron, JJ; Noël, G | 1 |
Abramson, A; Lin, YJ; Stamberg, J; Steinberg, BM; Zaslav, AL | 1 |
9 review(s) available for glutamine and Cancer of Head
Article | Year |
---|---|
Immunonutrition in head and neck cancer: Systematic review and metanalysis of its clinical and nutritional effects.
Topics: Chemoradiotherapy; Glutamine; Hand Strength; Head and Neck Neoplasms; Humans; Nutritional Status | 2021 |
Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
Topics: Glutamine; Head and Neck Neoplasms; Humans; Radiation Injuries; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Stomatitis | 2021 |
Immunonutrition for patients undergoing surgery for head and neck cancer.
Topics: Aged; Arginine; Cause of Death; Fatty Acids; Fistula; Food, Fortified; Glutamine; Head and Neck Neoplasms; Humans; Length of Stay; Malnutrition; Middle Aged; Postoperative Complications; Randomized Controlled Trials as Topic; Surgical Wound Infection | 2018 |
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements.
Topics: Dietary Supplements; Glutamine; Head and Neck Neoplasms; Humans; Minerals; Mucositis; Neoplasms; Stomatitis; Vitamins | 2019 |
Systematic review of natural agents for the management of oral mucositis in cancer patients.
Topics: Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Honey; Humans; Practice Guidelines as Topic; Stomatitis; Trace Elements; Vitamins; Zinc | 2013 |
The role of glutamine supplementation in thoracic and upper aerodigestive malignancies.
Topics: Dietary Supplements; Esophagitis; Glutamine; Head and Neck Neoplasms; Humans; Radiation Injuries; Randomized Controlled Trials as Topic; Stomatitis; Thoracic Neoplasms | 2015 |
Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis.
Topics: Databases, Factual; Glutamine; Head and Neck Neoplasms; Humans; Radiation Injuries; Radiation, Ionizing; Radiotherapy; Randomized Controlled Trials as Topic; Stomatitis | 2016 |
Strategies for managing radiation-induced mucositis in head and neck cancer.
Topics: Acetylcysteine; Amifostine; Carcinoma, Squamous Cell; Glutamine; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Low-Level Light Therapy; Mouthwashes; Oral Hygiene; Pain Management; Risk Factors; Stomatitis | 2009 |
Immunonutrition in head and neck cancer: have a look before surgery!
Topics: Animals; Arginine; Dietary Supplements; Fatty Acids, Unsaturated; Glutamine; Head and Neck Neoplasms; Humans; Immune Tolerance; Immunologic Factors; Malnutrition; Nucleotides; Preoperative Care; Wound Healing | 2012 |
6 trial(s) available for glutamine and Cancer of Head
Article | Year |
---|---|
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Topics: Arginine; Cachexia; Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Humans; Mucositis; Squamous Cell Carcinoma of Head and Neck | 2023 |
L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Glutamine; Head and Neck Neoplasms; Humans | 2023 |
Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
Topics: Adult; Aged; Dermatitis; Double-Blind Method; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Radiation Injuries; Radiotherapy; Stomatitis | 2019 |
Enteral glutamine supplementation in surgical patients with head and neck malignancy: A randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Body Mass Index; Dietary Supplements; Female; Glutamine; Head and Neck Neoplasms; Hospitals, University; Humans; Male; Middle Aged; Perioperative Care; Prospective Studies; Quality of Life; Serum Albumin; Treatment Outcome; Young Adult | 2015 |
L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Double-Blind Method; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Quality of Life; Treatment Outcome | 2015 |
Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial.
Topics: Administration, Oral; Body Weight; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pilot Projects; Radiation Injuries; Stomatitis | 2000 |
21 other study(ies) available for glutamine and Cancer of Head
Article | Year |
---|---|
ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
Topics: Animals; Autophagy; Autophagy-Related Protein 12; Fibroblasts; Glutamine; Head and Neck Neoplasms; Humans; Mice; Squamous Cell Carcinoma of Head and Neck; Tumor Hypoxia; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2022 |
Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
Topics: Animals; Apoptosis; Caprylates; Cell Line, Tumor; Cell Survival; Glutamine; Head and Neck Neoplasms; Humans; Mice; Sulfides | 2021 |
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers.
Topics: Glutaminase; Glutamine; Head and Neck Neoplasms; Humans | 2022 |
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.
Topics: Carcinoma, Squamous Cell; Glutamine; Head and Neck Neoplasms; Humans; Mitochondrial Proteins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thiolester Hydrolases | 2022 |
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Topics: Amino Acid Transport System ASC; Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cisplatin; Glutamate Dehydrogenase; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Ketoglutaric Acids; Metabolome; Mice; Mice, Nude; Minor Histocompatibility Antigens; Mitochondria; Molecular Targeted Therapy; Neoplastic Stem Cells; Oxidation-Reduction; Oxidative Stress; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Sulfasalazine | 2019 |
Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis.
Topics: Cell Culture Techniques; Cell Line; Glucose; Glutamine; Head and Neck Neoplasms; Humans; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species | 2019 |
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cetuximab; Disease Progression; Female; Glutamine; Head and Neck Neoplasms; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Minor Histocompatibility Antigens; Oxidative Stress; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients.
Topics: Adult; Aged; Arginine; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Squamous Cell Carcinoma of Head and Neck; X-ray Repair Cross Complementing Protein 1 | 2020 |
p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glucose; Glutaminase; Glutamine; Glutathione; Glycolysis; Head and Neck Neoplasms; Humans; NADP; Oxidation-Reduction; Oxidative Stress; Radiation Tolerance; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2021 |
The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cohort Studies; Esophagitis; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Nutritional Support; Quality of Life; Radiotherapy, Intensity-Modulated; Saliva; Surveys and Questionnaires; Xerostomia | 2016 |
Prevention of oral mucositis secondary to antineoplastic treatments in head and neck cancer by supplementation with oral glutamine.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Dietary Supplements; Female; Glutamine; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Prospective Studies; Stomatitis | 2018 |
Targeting cellular metabolism to reduce head and neck cancer growth.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease-Free Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Head and Neck Neoplasms; Humans; Metabolic Networks and Pathways; Metformin; Sulfides; Thiadiazoles | 2019 |
Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: a retrospective study.
Topics: Aged; Antineoplastic Agents; Body Mass Index; Cohort Studies; Enteral Nutrition; Esophagitis; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Malnutrition; Middle Aged; Nutritional Status; Radiotherapy; Retrospective Studies; Stomatitis; Weight Loss | 2013 |
DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Arginine; Case-Control Studies; DNA Helicases; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Glutamine; Guanine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Occupational Exposure; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Smoking; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein; Young Adult | 2014 |
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dichloroacetic Acid; Down-Regulation; Endocytosis; ErbB Receptors; Gefitinib; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Quinazolines; Reactive Oxygen Species; RNA Interference; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Transfection | 2016 |
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Topics: Amino Acid Transport System y+; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cisplatin; Cystine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Piperazines; Reactive Oxygen Species; RNA Interference; Sulfasalazine; Transfection; Xenograft Model Antitumor Assays | 2016 |
Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Colorectal Neoplasms; Esophageal Neoplasms; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Incidence; Isoleucine; Japan; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasms; Polymorphism, Single Nucleotide; Proline; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Risk Factors | 2010 |
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
Topics: Adenosine Triphosphate; Carcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Deoxyglucose; Disease Progression; Genes, p53; Glucose; Glutamine; Head and Neck Neoplasms; Humans; Lactic Acid; Mass Spectrometry; Metabolomics; Metformin; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Suppressor Protein p53 | 2011 |
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; Cisplatin; Cysteine; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Female; Gene Frequency; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2006 |
[Comments on five clinical trials concerning radiotherapy-induced mucositis in patients with head and neck neoplasms].
Topics: Amifostine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Glutamine; Granulocyte-Macrophage Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Pilot Projects; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Randomized Controlled Trials as Topic; Stomatitis; Sucralfate; Xerostomia | 2001 |
Cytogenetic analysis of head and neck carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 14; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Skin Neoplasms; Tumor Cells, Cultured | 1991 |